Financhill
Back

Axcelis Technologies Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
58

ACLS
Axcelis Technologies

Last Price:
107.41
Seasonality Move:
13.58%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
58
Axcelis Technologies (ACLS) is a Buy

Is Axcelis Technologies a Buy, Sell or Hold?

  • The current Axcelis Technologies [ACLS] share price is $107.37. The Score for ACLS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • ACLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACLS Stock Price Chart

What is Axcelis Technologies's stock price today?

  • The Axcelis Technologies share price today is $107.37
    The current trend is relatively stagnant and ACLS is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

ACLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.62 Sell
Relative Strength Index (14 RSI): 53.03 Buy
Chaikin Money Flow: -198407 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.57 - 108.19) Buy
Bollinger Bands (100): (104.14 - 134.56) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

ACLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.1 Buy
20-day SMA: 101.56 Buy
50-day SMA: 110.17 Sell
200-day SMA: 118.23 Sell
8-day EMA: 104.04 Buy
20-day EMA: 104.01 Buy
50-day EMA: 109.79 Sell
200-day EMA: 119.75 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Axcelis Technologies Earnings Growth & ACLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.38 per share, and an increase next year of $1.50 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Axcelis Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):